연구성과로 돌아가기
JCR 2022 저널 목록 (1451 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case Reports in Endocrinology | HINDAWI LTD | 2090-6501 | 2090-651X | ESCI | ENDOCRINOLOGY & METABOLISM | 471 | 1.1 | N/A | 100.0 | N/A | N/A | 1.0 | N/A | 1.1 | 0.1 | 0.20 | 162/184 | Q4 | 12.23 | 0.001 | 0.117 | 0.199 | Q3 | 46 | 84.8% | 4.5 | 8.7 | 39 | 99.4% | 2025-04-21 09:50:08 | 바로가기 |
| Case Reports in Gastroenterology | KARGER | N/A | 1662-0631 | ESCI | GASTROENTEROLOGY & HEPATOLOGY | 846 | 0.6 | N/A | 100.0 | N/A | N/A | N/A | N/A | 0.6 | 0.1 | 0.15 | 124/139 | Q4 | 11.15 | 0.001 | 0.211 | N/A | N/A | 108 | 87.0% | 6.6 | 9.0 | 94 | 99.7% | 2025-04-21 09:57:37 | 바로가기 |
| Case Reports in Gastrointestinal Medicine | HINDAWI LTD | 2090-6528 | 2090-6536 | ESCI | GASTROENTEROLOGY & HEPATOLOGY | 414 | 0.7 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.7 | 0.1 | 0.12 | 129/139 | Q4 | 7.55 | 0.000 | 0.108 | 0.165 | Q4 | 33 | 84.8% | 5.2 | 9.3 | 28 | 99.3% | 2025-04-21 09:57:38 | 바로가기 |
| Case Reports in Hematology | HINDAWI LTD | 2090-6560 | 2090-6579 | ESCI | HEMATOLOGY | 549 | 0.7 | N/A | 100.0 | N/A | N/A | 0.8 | N/A | 0.7 | 0.3 | 0.16 | 85/97 | Q4 | 12.89 | 0.001 | 0.154 | 0.193 | Q3 | 57 | 87.7% | 5.0 | 6.0 | 50 | 99.5% | 2025-04-21 10:00:52 | 바로가기 |
| Case Reports in Immunology | HINDAWI LTD | 2090-6609 | 2090-6617 | ESCI | IMMUNOLOGY | 104 | 1.0 | N/A | 100.0 | N/A | N/A | 1.2 | N/A | 1.0 | <0.1 | 0.21 | 165/177 | Q4 | 7.06 | 0.000 | 0.029 | 0.272 | Q3 | 12 | 91.7% | 4.8 | 7.3 | 11 | 100.0% | 2025-04-21 10:04:20 | 바로가기 |
| Case Reports in Infectious Diseases | HINDAWI LTD | 2090-6625 | 2090-6633 | ESCI | INFECTIOUS DISEASES | 760 | 1.1 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 1.1 | 0.2 | 0.19 | 116/129 | Q4 | 10.47 | 0.001 | 0.201 | 0.220 | Q3 | 70 | 91.4% | 4.8 | 7.1 | 64 | 99.6% | 2025-04-21 10:04:50 | 바로가기 |
| Case Reports in Medicine | HINDAWI LTD | 1687-9627 | 1687-9635 | ESCI | MEDICINE, GENERAL & INTERNAL | 1,452 | 0.8 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 0.8 | 0.3 | 0.20 | 199/327 | Q3 | 39.30 | 0.001 | 0.207 | 0.208 | Q2 | 60 | 83.3% | 8.0 | 7.8 | 50 | 97.6% | 2025-04-21 10:15:17 | 바로가기 |
| Case Reports in Nephrology and Dialysis | KARGER | 2296-9705 | 2296-9705 | ESCI | UROLOGY & NEPHROLOGY | 205 | 0.7 | N/A | 100.0 | N/A | N/A | 0.8 | N/A | 0.7 | 0.2 | 0.28 | 103/125 | Q4 | 18.00 | 0.000 | 0.056 | 0.190 | Q3 | 39 | 84.6% | 4.5 | 8.6 | 33 | 100.0% | 2025-04-21 10:40:18 | 바로가기 |
| Case Reports in Neurological Medicine | HINDAWI LTD | 2090-6668 | 2090-6676 | ESCI | CLINICAL NEUROLOGY | 500 | 0.9 | N/A | 100.0 | N/A | N/A | 0.8 | N/A | 0.9 | 0.3 | 0.26 | 238/269 | Q4 | 11.71 | 0.000 | 0.101 | 0.204 | Q3 | 28 | 96.4% | 6.3 | 8.5 | 27 | 98.2% | 2025-04-21 09:39:22 | 바로가기 |
| Case Reports in Neurology | KARGER | N/A | 1662-680X | ESCI | CLINICAL NEUROLOGY | 510 | 0.7 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.7 | 0.2 | 0.18 | 248/269 | Q4 | 7.99 | 0.001 | 0.128 | 0.170 | Q3 | 73 | 90.4% | 4.5 | 8.8 | 66 | 99.0% | 2025-04-21 09:39:22 | 바로가기 |
| Case Reports in Oncological Medicine | HINDAWI LTD | 2090-6706 | 2090-6714 | ESCI | ONCOLOGY | 564 | 0.9 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 0.9 | 0.3 | 0.16 | 288/318 | Q4 | 9.59 | 0.001 | 0.122 | 0.202 | Q3 | 12 | 91.7% | 5.9 | 6.0 | 11 | 98.2% | 2025-04-21 10:20:54 | 바로가기 |
| Case Reports in Oncology | KARGER | 1662-6575 | 1662-6575 | ESCI | ONCOLOGY | 1,320 | 0.8 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 0.7 | 0.1 | 0.16 | 288/318 | Q4 | 9.59 | 0.002 | 0.383 | 0.202 | Q3 | 165 | 92.1% | 4.5 | 6.9 | 152 | 99.4% | 2025-04-21 10:20:52 | 바로가기 |
| Case Reports in Ophthalmological Medicine | HINDAWI LTD | 2090-6722 | 2090-6730 | ESCI | OPHTHALMOLOGY | 377 | 0.9 | N/A | 100.0 | N/A | N/A | 0.8 | N/A | 0.9 | 0.1 | 0.31 | 81/95 | Q4 | 15.26 | 0.000 | 0.091 | 0.193 | Q4 | 43 | 93.0% | 5.2 | 10.0 | 40 | 99.4% | 2025-04-21 10:21:51 | 바로가기 |
| Case Reports in Ophthalmology | KARGER | 1663-2699 | N/A | ESCI | OPHTHALMOLOGY | 602 | 0.4 | N/A | 100.0 | N/A | N/A | 0.6 | N/A | 0.4 | 0.1 | 0.22 | 84/95 | Q4 | 12.11 | 0.001 | 0.130 | 0.134 | Q4 | 166 | 96.4% | 6.0 | 8.6 | 160 | 100.0% | 2025-04-21 10:21:50 | 바로가기 |
| Case Reports in Otolaryngology | HINDAWI LTD | 2090-6765 | 2090-6773 | ESCI | OTORHINOLARYNGOLOGY | 423 | 0.6 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.6 | 0.1 | 0.27 | 53/64 | Q4 | 17.97 | 0.000 | 0.079 | 0.162 | Q2 | 18 | 77.8% | 6.7 | 10.8 | 14 | 99.0% | 2025-04-21 10:22:39 | 바로가기 |
페이지 이동: